These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 1439691

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Prevention and treatment of osteoporosis.
    Schapira D.
    Compr Ther; 1990 Mar; 16(3):27-33. PubMed ID: 2180627
    [No Abstract] [Full Text] [Related]

  • 23. Osteoporosis management.
    Rozenberg S, Vandromme J, Ayata NB, Filippidis M, Kroll M.
    Int J Fertil Womens Med; 1999 Mar; 44(5):241-9. PubMed ID: 10569453
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Secondary hyperparathyroidism in primary osteoporosis and osteopenia: optimizing calcium and vitamin D intakes to levels recommended by expert panels may not be sufficient for correction.
    Yendt ER, Kovacs KA, Jones G.
    Clin Endocrinol (Oxf); 2008 Dec; 69(6):855-63. PubMed ID: 18419790
    [Abstract] [Full Text] [Related]

  • 26. [Postmenopausal osteoporosis].
    László A.
    Orv Hetil; 2004 Jan 04; 145(1):3-13. PubMed ID: 15222134
    [Abstract] [Full Text] [Related]

  • 27. [Treatment of osteoporosis].
    Salmi J, Välimäki M.
    Duodecim; 1996 Jan 04; 112(22):2131-8. PubMed ID: 10605219
    [No Abstract] [Full Text] [Related]

  • 28. Office management of osteoporosis: a guide for the primary care provider.
    Daly PA.
    Compr Ther; 1995 Oct 04; 21(10):565-74. PubMed ID: 8565424
    [Abstract] [Full Text] [Related]

  • 29. Prevention and treatment of postmenopausal osteoporosis. National consensus of the "Belgian Bone Club"--September 1993.
    Clin Rheumatol; 1995 Sep 04; 14 Suppl 3():7-8. PubMed ID: 8846660
    [No Abstract] [Full Text] [Related]

  • 30. Prevention of osteoporosis and uterine effects in postmenopausal women taking raloxifene for 5 years.
    Jolly EE, Bjarnason NH, Neven P, Plouffe L, Johnston CC, Watts SD, Arnaud CD, Mason TM, Crans G, Akers R, Draper MW.
    Menopause; 2003 Sep 04; 10(4):337-44. PubMed ID: 12851517
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Selective estrogen receptor modulators (SERM): new substances for hormone replacement therapy].
    Burckhardt P.
    Schweiz Med Wochenschr; 1999 Dec 11; 129(49):1926-30. PubMed ID: 10635085
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Treatment of osteoporosis: current data and prospects].
    Reginster JY, Deroisy R, Franchimont P.
    Rev Rhum Ed Fr; 1994 Dec 15; 61(10 Pt 2):155S-164S. PubMed ID: 7858567
    [Abstract] [Full Text] [Related]

  • 36. Osteoporosis: handy tools for detection, helpful tips for treatment.
    Morgan SL, Kitchin B.
    J Fam Pract; 2008 May 15; 57(5):311-20. PubMed ID: 18460296
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. A cost effectiveness analysis of calcium and vitamin D supplementation, etidronate, and alendronate in the prevention of vertebral fractures in women treated with glucocorticoids.
    Buckley LM, Hillner BE.
    J Rheumatol; 2003 Jan 15; 30(1):132-8. PubMed ID: 12508402
    [Abstract] [Full Text] [Related]

  • 39. What is adequate?
    Jones AB.
    Can Fam Physician; 2006 Sep 15; 52(9):1059; author reply 1059-60. PubMed ID: 17279209
    [No Abstract] [Full Text] [Related]

  • 40. [Therapeutic strategies for osteoporosis].
    Chapurlat R, Delmas PD.
    Ann Med Interne (Paris); 2000 Oct 15; 151(6):471-6. PubMed ID: 11104926
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.